Vista Pharmaceuticals Ltd
BSE:524711
Cash Flow Statement
Cash Flow Statement
Vista Pharmaceuticals Ltd
| Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||
| Net Income |
(37)
|
(32)
|
(26)
|
(22)
|
(59)
|
(76)
|
(52)
|
(47)
|
(53)
|
(80)
|
|
| Depreciation & Amortization |
7
|
7
|
6
|
6
|
6
|
7
|
7
|
7
|
7
|
7
|
|
| Other Non-Cash Items |
15
|
10
|
8
|
7
|
12
|
15
|
12
|
11
|
10
|
9
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
(11)
|
(11)
|
0
|
0
|
4
|
4
|
|
| Cash Interest Paid |
15
|
9
|
9
|
10
|
12
|
14
|
12
|
11
|
10
|
8
|
|
| Change in Working Capital |
(53)
|
(17)
|
1
|
3
|
23
|
11
|
(17)
|
(43)
|
(34)
|
9
|
|
| Cash from Operating Activities |
(67)
N/A
|
(32)
+53%
|
(10)
+69%
|
(6)
+39%
|
(17)
-185%
|
(43)
-151%
|
(49)
-15%
|
(71)
-45%
|
(70)
+2%
|
(55)
+21%
|
|
| Investing Cash Flow | |||||||||||
| Capital Expenditures |
(3)
|
(2)
|
(0)
|
0
|
(13)
|
(18)
|
(8)
|
(5)
|
(4)
|
(9)
|
|
| Cash from Investing Activities |
(3)
N/A
|
(2)
+30%
|
(0)
+93%
|
0
N/A
|
(13)
N/A
|
(18)
-42%
|
(8)
+56%
|
(5)
+35%
|
(4)
+14%
|
(9)
-107%
|
|
| Financing Cash Flow | |||||||||||
| Net Issuance of Common Stock |
90
|
0
|
0
|
0
|
69
|
118
|
83
|
130
|
96
|
31
|
|
| Net Issuance of Debt |
(5)
|
41
|
7
|
(9)
|
(22)
|
(24)
|
(14)
|
(19)
|
0
|
22
|
|
| Other |
(15)
|
(9)
|
3
|
15
|
(16)
|
(31)
|
(12)
|
(11)
|
(10)
|
(8)
|
|
| Cash from Financing Activities |
70
N/A
|
32
-54%
|
9
-71%
|
6
-36%
|
31
+420%
|
63
+101%
|
56
-11%
|
100
+79%
|
86
-14%
|
45
-48%
|
|
| Change in Cash | |||||||||||
| Net Change in Cash |
(1)
N/A
|
(2)
-86%
|
(1)
+57%
|
(0)
+98%
|
1
N/A
|
2
+29%
|
(1)
N/A
|
24
N/A
|
12
-50%
|
(19)
N/A
|
|
| Free Cash Flow | |||||||||||
| Free Cash Flow |
(70)
N/A
|
(34)
+52%
|
(10)
+70%
|
(6)
+40%
|
(30)
-397%
|
(61)
-104%
|
(57)
+6%
|
(76)
-34%
|
(74)
+3%
|
(64)
+13%
|
|